This is an Open Label or Placebo Controlled Safety and Efficacy Study of an Investigational Medicine for COVID-19 in Adults.


Clinical Trial for Migraine in Children

Clinical Trial of an Antibody Cocktail for COVID-19

Study Location(s): Owensboro Kentucky, Evansville Indiana

Qualmedica Research is currently enrolling two clinical trials focused on a new antibody therapy developed by Eli Lilly.  The BLAZE 1 study is for pediatric patients age 0 – 17 with underlying risk factors.  The BLAZE 4 study is for patients 12 years and older with underlying risk factors.  You may qualify if you have recenltly tested positive for COVID-19.  If you are exhibiting symptoms of COVID-19, Qualmedica Research may administer a free rapid antigen test to see if you qualify for one of these studies.

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimbursement up to $3000 may be available.

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest